European Pharmaceutical Review Issue 1 2026

Our latest issue places a focus on the scientific, regulatory and technological forces redefining pharmaceuticals today.

Analytical & regulatory foundations

Analytical excellence remains a key cornerstone of the industry, and we showcase how automation in ion chromatography is driving reliability and efficiency in routine workflows. Complementing this is a thorough analysis into clinical trial innovation, examining how Bayesian approaches - supported by new regulatory guidance - are enabling more agile and efficient study designs.

We’ll share a detailed examination of solvents and compliance with ICH Q3C guidelines, highlighting the evolving expectations around residual solvent control and global harmonisation. From there, we move into the cutting edge of mass spectrometry, exploring how high-resolution ion mobility is unlocking new possibilities in oligonucleotide characterisation.

Sustainability & manufacturing challenges

Our feature on biodiversity footprinting explores how organisations can better assess and mitigate environmental impact across increasingly complex supply chains. Alongside this, we address the realities of manufacturing, where scaling AAV innovation from concept to commercial production presents both technical and strategic challenges.

Quality, monitoring & microbiology

In aseptic processing, the shift towards real-time environmental monitoring is gathering pace. We examine how digital tools are enabling faster, more actionable insights to strengthen contamination control. In parallel, a novel AI-driven microbiological method demonstrates how rapid detection, enumeration and identification could transform quality assurance frameworks.

Advanced therapies & bioprocessing

We explore the complexities of scaling cell therapies from clinical development to commercial delivery. In bioprocessing, targeted integration strategies are shown to accelerate stable cell line development, supporting greater consistency and efficiency in biologics manufacturing.

Core processes & technical fundamentals

We revisit the fundamentals of lyophilisation with a practical look at product temperature measurement, reinforcing its critical role in ensuring robust and reproducible freeze-drying processes.

Drug delivery & formulation innovation

Our drug delivery section highlights the latest advances in formulation science. From lipid-based approaches that enhance dissolution to mechanically targeted delivery systems for stroke treatment, these features demonstrate how innovation is reshaping therapeutic effectiveness. Additional insights explore why softgel technologies continue to gain traction and how formulation strategies are evolving to meet increasingly complex drug profiles.

Applications, testing & industry 4.0

This issue also delivers a range of application-driven insights, including high-throughput automated solutions for endotoxin testing and the role of smart manufacturing in advancing quality management maturity. We also examine how testing strategies are shifting from simple identification towards deeper analytical understanding and interpretation.

Looking ahead

Finally, our event preview of The Future of Bio/Pharmaceutical Analysis 2026 offers a glimpse into the key discussions and innovations set to shape the year ahead.

Packed with authoritative voices, practical solutions and strategic insight, this issue is essential reading for those navigating the complexities of modern pharmaceutical development and manufacturing.

Interested? Register your details to find out more.